| Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non … JC Soria, A Mauguen, M Reck, AB Sandler, N Saijo, DH Johnson, ... Annals of oncology 24 (1), 20-30, 2013 | 389 | 2013 |
| Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis A Mauguen, C Le Péchoux, MI Saunders, SE Schild, AT Turrisi, ... Journal of Clinical Oncology 30 (22), 2788, 2012 | 309 | 2012 |
| Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual … A Mauguen, JP Pignon, S Burdett, C Domerg, D Fisher, R Paulus, ... The lancet oncology 14 (7), 619-626, 2013 | 241 | 2013 |
| Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial MC Le Deley, A Rosolen, DM Williams, K Horibe, G Wrobel, A Attarbaschi, ... Journal of Clinical Oncology 28 (25), 3987-3993, 2010 | 225 | 2010 |
| COVID-19 in children with cancer in New York City F Boulad, M Kamboj, N Bouvier, A Mauguen, AL Kung JAMA oncology 6 (9), 1459-1460, 2020 | 216 | 2020 |
| Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study L Lamant, K McCarthy, E d'Amore, W Klapper, A Nakagawa, M Fraga, ... Journal of Clinical Oncology 29 (35), 4669-4676, 2011 | 171 | 2011 |
| Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical … JP Kilday, B Mitra, C Domerg, J Ward, F Andreiuolo, T Osteso-Ibanez, ... Clinical Cancer Research 18 (7), 2001-2011, 2012 | 117 | 2012 |
| Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer C Touboul, C Uzan, A Mauguen, S Gouy, A Rey, P Pautier, C Lhommé, ... The oncologist 15 (4), 405-415, 2010 | 112 | 2010 |
| Head-to-head evaluation of 18F-FES and 18F-FDG PET/CT in metastatic invasive lobular breast cancer GA Ulaner, K Jhaveri, S Chandarlapaty, V Hatzoglou, CC Riedl, JS Lewis, ... Journal of Nuclear Medicine 62 (3), 326-331, 2021 | 93 | 2021 |
| Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors EM Fiala, G Jayakumaran, A Mauguen, JA Kennedy, N Bouvier, Y Kemel, ... Nature Cancer 2 (3), 357-365, 2021 | 91 | 2021 |
| Levels of circulating CD45 dim CD34+ VEGFR2+ progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors F Farace, M Gross-Goupil, E Tournay, M Taylor, N Vimond, N Jacques, ... British journal of cancer 104 (7), 1144-1150, 2011 | 79 | 2011 |
| Auditory stimuli mimicking ambient sounds drive temporal “delta-brushes” in premature infants M Chipaux, MT Colonnese, A Mauguen, L Fellous, M Mokhtari, ... PloS one 8 (11), e79028, 2013 | 75 | 2013 |
| Tutorial in joint modeling and prediction: a statistical software for correlated longitudinal outcomes, recurrent events and a terminal event A Król, A Mauguen, Y Mazroui, A Laurent, S Michiels, V Rondeau arXiv preprint arXiv:1701.03675, 2017 | 72 | 2017 |
| Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non–small-cell lung cancer treated by … J Cadranel, A Mauguen, M Faller, G Zalcman, MP Buisine, V Westeel, ... Journal of Thoracic Oncology 7 (10), 1490-1502, 2012 | 72 | 2012 |
| Neuronal differentiation distinguishes supratentorial and infratentorial childhood ependymomas F Andreiuolo, S Puget, M Peyre, C Dantas-Barbosa, N Boddaert, ... Neuro-oncology 12 (11), 1126-1134, 2010 | 71 | 2010 |
| Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by … M Beau-Faller, A Degeorges, E Rolland, M Mounawar, M Antoine, ... Journal of Thoracic Oncology 6 (6), 1006-1015, 2011 | 70 | 2011 |
| Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma with Prior Disease Progression IY Cheung, NKV Cheung, S Modak, A Mauguen, Y Feng, E Basu, ... Journal of Clinical Oncology 39 (3), 215-226, 2021 | 68 | 2021 |
| Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis M Peyre, F Commo, C Dantas-Barbosa, F Andreiuolo, S Puget, L Lacroix, ... PloS one 5 (9), e12932, 2010 | 67 | 2010 |
| Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results F Boulad, T Shore, K van Besien, C Minniti, M Barbu-Stevanovic, ... haematologica 103 (5), 770, 2018 | 64 | 2018 |
| Dynamic prediction of risk of death using history of cancer recurrences in joint frailty models A Mauguen, B Rachet, S Mathoulin‐Pélissier, G MacGrogan, A Laurent, ... Statistics in medicine 32 (30), 5366-5380, 2013 | 64 | 2013 |
